PA8467301A1 - Nuevos derivados del acido dihidroxihexanoico - Google Patents
Nuevos derivados del acido dihidroxihexanoicoInfo
- Publication number
- PA8467301A1 PA8467301A1 PA19998467301A PA8467301A PA8467301A1 PA 8467301 A1 PA8467301 A1 PA 8467301A1 PA 19998467301 A PA19998467301 A PA 19998467301A PA 8467301 A PA8467301 A PA 8467301A PA 8467301 A1 PA8467301 A1 PA 8467301A1
- Authority
- PA
- Panama
- Prior art keywords
- acid
- dihydroxyhexanic
- new derivatives
- derivatives
- new
- Prior art date
Links
- IPCSIKXLXDFUAC-UHFFFAOYSA-N 2,2-dihydroxyhexanoic acid Chemical class CCCCC(O)(O)C(O)=O IPCSIKXLXDFUAC-UHFFFAOYSA-N 0.000 title abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7380198P | 1998-02-05 | 1998-02-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8467301A1 true PA8467301A1 (es) | 2000-05-24 |
Family
ID=22115885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA19998467301A PA8467301A1 (es) | 1998-02-05 | 1999-01-18 | Nuevos derivados del acido dihidroxihexanoico |
Country Status (36)
| Country | Link |
|---|---|
| EP (1) | EP1051405B1 (OSRAM) |
| JP (1) | JP3693916B2 (OSRAM) |
| KR (1) | KR100385529B1 (OSRAM) |
| CN (1) | CN1177834C (OSRAM) |
| AP (1) | AP992A (OSRAM) |
| AR (1) | AR016175A1 (OSRAM) |
| AT (1) | ATE337307T1 (OSRAM) |
| AU (1) | AU752407B2 (OSRAM) |
| BG (1) | BG104726A (OSRAM) |
| BR (1) | BR9907655A (OSRAM) |
| CA (1) | CA2320388C (OSRAM) |
| DE (1) | DE69932920T2 (OSRAM) |
| DZ (1) | DZ2717A1 (OSRAM) |
| EA (1) | EA003137B1 (OSRAM) |
| ES (1) | ES2268847T3 (OSRAM) |
| GT (1) | GT199900011A (OSRAM) |
| HR (1) | HRP20000529B1 (OSRAM) |
| HU (1) | HUP0100832A3 (OSRAM) |
| IL (1) | IL137330A0 (OSRAM) |
| IS (1) | IS5562A (OSRAM) |
| MA (1) | MA26603A1 (OSRAM) |
| MY (1) | MY133125A (OSRAM) |
| NO (1) | NO20003965D0 (OSRAM) |
| NZ (1) | NZ505724A (OSRAM) |
| OA (1) | OA11448A (OSRAM) |
| PA (1) | PA8467301A1 (OSRAM) |
| PE (1) | PE20000243A1 (OSRAM) |
| PL (1) | PL342817A1 (OSRAM) |
| SK (1) | SK11262000A3 (OSRAM) |
| TN (1) | TNSN99013A1 (OSRAM) |
| TR (1) | TR200002248T2 (OSRAM) |
| TW (1) | TW470744B (OSRAM) |
| UA (1) | UA57824C2 (OSRAM) |
| WO (1) | WO1999040061A2 (OSRAM) |
| YU (1) | YU47100A (OSRAM) |
| ZA (1) | ZA99873B (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2360672A1 (en) * | 1999-01-29 | 2000-08-03 | Wayne W. Hancock | Methods for preventing graft rejection and ischemia-reperfusion injury |
| EP1204643B1 (en) * | 1999-08-20 | 2008-06-04 | Dow AgroSciences LLC | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| EP1498417A1 (en) * | 2000-02-04 | 2005-01-19 | Pfizer Products Inc. | Heterocyclic amide derivatives |
| PL357094A1 (en) | 2000-02-04 | 2004-07-12 | Pfizer Products Inc. | Heterocyclic amide derivatives |
| US6740636B2 (en) * | 2000-07-31 | 2004-05-25 | Schering Aktiengesellschaft | Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection |
| US6746856B2 (en) | 2000-08-09 | 2004-06-08 | Pfizer Inc. | Microbial conversion of bicyclic heteroaromatic compounds |
| ES2333645T3 (es) | 2001-06-22 | 2010-02-25 | Bend Research, Inc. | Composiciones farmaceuticas de dispersiones de medicamentos y polimeros neutros. |
| EP1269994A3 (en) * | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| CA2448825C (en) | 2001-06-22 | 2009-08-11 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drug |
| DE10152351B4 (de) * | 2001-10-18 | 2005-09-22 | Schering Ag | Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat |
| ES2305434T3 (es) | 2002-02-01 | 2008-11-01 | Pfizer Products Inc. | Composiciones framaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas. |
| JP2005527604A (ja) * | 2002-05-14 | 2005-09-15 | ファイザー・プロダクツ・インク | ジヒドロフラン２オン誘導体の製造方法 |
| WO2003095440A1 (en) | 2002-05-14 | 2003-11-20 | Pfizer Products Inc. | Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making |
| ES2333318T3 (es) | 2002-08-12 | 2010-02-19 | Bend Research, Inc. | Composiciones farmaceuticas de medicamentos con estructura semiordenada y de polimero. |
| BR0313378A (pt) * | 2002-08-12 | 2005-07-12 | Pfizer Producs Inc | Formas cristalinas da [4carbamoil-1-(3-fluorobenzil)-2,7-dihidróxi-7-metil-o ctil]-amida do ácido quinoxalina-2-carboxìlico |
| US20040097554A1 (en) * | 2002-10-30 | 2004-05-20 | Pfizer Inc | Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents |
| US20040087571A1 (en) * | 2002-10-30 | 2004-05-06 | Pfizer Inc | Methods of using CCR1 antagonists as immunomodulatory agents |
| BRPI0413277A (pt) | 2003-08-04 | 2006-10-10 | Pfizer Prod Inc | composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923864A (en) * | 1987-12-15 | 1990-05-08 | Pfizer Inc. | Certain heterocyclic-hexanamides useful for treating hypertension |
| ATE220661T1 (de) * | 1994-10-19 | 2002-08-15 | Novartis Erfind Verwalt Gmbh | Antivirale ether von aspartat-protease-substrat- isosteren |
| DE19708106A1 (de) * | 1997-02-28 | 1998-09-03 | Bosch Gmbh Robert | Einrichtung und Verfahren zur Information über Verkehrsstörungen |
-
1999
- 1999-01-18 KR KR10-2000-7008561A patent/KR100385529B1/ko not_active Expired - Fee Related
- 1999-01-18 ES ES99900098T patent/ES2268847T3/es not_active Expired - Lifetime
- 1999-01-18 PL PL99342817A patent/PL342817A1/xx not_active Application Discontinuation
- 1999-01-18 EP EP99900098A patent/EP1051405B1/en not_active Expired - Lifetime
- 1999-01-18 HU HU0100832A patent/HUP0100832A3/hu unknown
- 1999-01-18 YU YU47100A patent/YU47100A/sh unknown
- 1999-01-18 TR TR2000/02248T patent/TR200002248T2/xx unknown
- 1999-01-18 CA CA002320388A patent/CA2320388C/en not_active Expired - Fee Related
- 1999-01-18 SK SK1126-2000A patent/SK11262000A3/sk unknown
- 1999-01-18 HR HR20000529 patent/HRP20000529B1/xx not_active IP Right Cessation
- 1999-01-18 IL IL13733099A patent/IL137330A0/xx unknown
- 1999-01-18 BR BR9907655-1A patent/BR9907655A/pt not_active Application Discontinuation
- 1999-01-18 CN CNB998027138A patent/CN1177834C/zh not_active Expired - Fee Related
- 1999-01-18 WO PCT/IB1999/000067 patent/WO1999040061A2/en not_active Ceased
- 1999-01-18 DE DE69932920T patent/DE69932920T2/de not_active Expired - Lifetime
- 1999-01-18 AU AU17789/99A patent/AU752407B2/en not_active Ceased
- 1999-01-18 UA UA2000074534A patent/UA57824C2/uk unknown
- 1999-01-18 PA PA19998467301A patent/PA8467301A1/es unknown
- 1999-01-18 AT AT99900098T patent/ATE337307T1/de not_active IP Right Cessation
- 1999-01-18 EA EA200000741A patent/EA003137B1/ru not_active IP Right Cessation
- 1999-01-18 NZ NZ505724A patent/NZ505724A/xx unknown
- 1999-01-18 JP JP2000530493A patent/JP3693916B2/ja not_active Expired - Lifetime
- 1999-01-27 GT GT199900011A patent/GT199900011A/es unknown
- 1999-02-01 PE PE1999000071A patent/PE20000243A1/es not_active Application Discontinuation
- 1999-02-01 TW TW088101505A patent/TW470744B/zh not_active IP Right Cessation
- 1999-02-03 AR ARP990100443A patent/AR016175A1/es unknown
- 1999-02-03 DZ DZ990018A patent/DZ2717A1/xx active
- 1999-02-03 MA MA25448A patent/MA26603A1/fr unknown
- 1999-02-03 TN TNTNSN99013A patent/TNSN99013A1/fr unknown
- 1999-02-03 MY MYPI99000363A patent/MY133125A/en unknown
- 1999-02-04 AP APAP/P/1999/001457A patent/AP992A/en active
- 1999-02-04 ZA ZA9900873A patent/ZA99873B/xx unknown
-
2000
- 2000-07-14 IS IS5562A patent/IS5562A/is unknown
- 2000-07-28 OA OA1200000214A patent/OA11448A/en unknown
- 2000-08-04 NO NO20003965A patent/NO20003965D0/no not_active Application Discontinuation
- 2000-08-29 BG BG104726A patent/BG104726A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8467301A1 (es) | Nuevos derivados del acido dihidroxihexanoico | |
| HN1998000035A (es) | Nuevos derivados del acido hexanoico | |
| ES2138691T3 (es) | Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina. | |
| CU23029A3 (es) | Analogos sustituidos del benzopirano para el tratamiento de la inflamacion | |
| AR010062A1 (es) | Nuevos benzamidaldehidos y su utilizacion | |
| AR005703A1 (es) | Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen | |
| UY26058A1 (es) | Compuestos utiles como antiinflamatorios ley 17.164 art. 127 | |
| AR023777A1 (es) | Nuevos compuestos | |
| ATE288431T1 (de) | Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum | |
| ES2186015T3 (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol. | |
| PT977748E (pt) | Derivados benzopirano substituidos para o tratamento de inflamacao | |
| ES2184797T3 (es) | Uso de antagonistas de serotonina (5ht3) para el tratamiento de la fibromialgia. | |
| ES2150808T3 (es) | Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico. | |
| ATE386742T1 (de) | Imidazonaphthyridine | |
| DK0869965T3 (da) | Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler | |
| DK0971922T3 (da) | Tetrahydropyrido-forbindelser | |
| ES2155621T3 (es) | Derivados azo del acido 5-aminosalicilico para el tratamiento de la enfermedad inflamatoria intestinal. | |
| ES2177811T3 (es) | Uso de nitroflavonoides para el tratamiento de la ansiedad. | |
| ES2167721T3 (es) | Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica. | |
| ECSP003590A (es) | Compuestos calcioliticos | |
| ES2164765T3 (es) | Heterociclilbenzonitrilos. | |
| ES2052391T3 (es) | Derivados de acido 5-aminosalicilico para la terapia de enfermedades inflamatorias cronicas del intestino. | |
| ECSP992841A (es) | Nuevos derivados del acido dihidroxihexanoico | |
| IT1258788B (it) | Derivati solforati di acidi biliari | |
| ATE204167T1 (de) | Antikonvulsive derivate zur behandlung von psoriasis |